1. Home
  2. DSGN vs SCHL Comparison

DSGN vs SCHL Comparison

Compare DSGN & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Design Therapeutics Inc.

DSGN

Design Therapeutics Inc.

N/A

Current Price

$11.94

Market Cap

853.8M

Sector

Health Care

ML Signal

N/A

Logo Scholastic Corporation

SCHL

Scholastic Corporation

N/A

Current Price

$40.99

Market Cap

790.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
DSGN
SCHL
Founded
2017
1920
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Books
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
853.8M
790.4M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
DSGN
SCHL
Price
$11.94
$40.99
Analyst Decision
Strong Buy
Hold
Analyst Count
4
1
Target Price
$15.25
$40.00
AVG Volume (30 Days)
697.6K
309.8K
Earning Date
04-28-2026
03-19-2026
Dividend Yield
N/A
1.99%
EPS Growth
N/A
3442.86
EPS
N/A
2.34
Revenue
N/A
$1,487,100,000.00
Revenue This Year
N/A
$1.88
Revenue Next Year
N/A
$4.05
P/E Ratio
N/A
$17.41
Revenue Growth
N/A
N/A
52 Week Low
$3.76
$22.69
52 Week High
$17.25
$48.07

Technical Indicators

Market Signals
Indicator
DSGN
SCHL
Relative Strength Index (RSI) 41.74 29.80
Support Level $11.94 $37.84
Resistance Level $13.54 $43.97
Average True Range (ATR) 0.86 1.59
MACD -0.24 -0.86
Stochastic Oscillator 15.49 8.33

Price Performance

Historical Comparison
DSGN
SCHL

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: